Our paper of the month for March is a phase 3 multicentre, double-blind, randomised trial investigating whether treatment with exenatide can slow the progression of Parkinson’s disease.
We are delighted to announce the three winners of our EAN 2025 Congress Quiz, each of whom has won free registration for the 10th Congress of the European Academy of Neurology in Helsinki!
EAN Treasurer, Jana Midelfart-Hoff reviews her "fantastic experience" in office over the last six months, representing the EAN and the Brain Health Mission on various levels
Each month the eanNews editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for February 2025.
For February we have selected two co-papers of the month, each of which examines the safety and efficacy of a specific drug in the treatment of patients with generalised myasthenia gravis.
The EAN is delighted to announce the launch of the third cohort of our dedicated guideline education programme – CoCoCare (Cost-Conscious Healthcare) 2025.
The European Journal of Neurology and the European Academy of Neurology are launching a new benefit to reward our most productive reviewers from January 2024 onwards.
We are excited to introduce a new competition, Your EAN Congress Story, giving you the chance to win free registration for the EAN Congress 2025 in Helsinki, Finland on 21-24 June 2025!
A new EAN paper published in the European Journal of Neurology presents a roadmap toward reducing the burden imposed on patients, caregivers, and society by neurological diseases in Europe.
EAN Programme Committee Chair, Irena Rektorova, provides an extensive preview of the EAN Congress 2025, looking at programme highlights, new features, and how you can get involved!